As shown in Figure 2, higher MAD2 expression was associated with a non-significant increased risk of all-cause mortality in a range of cancers (pooled HR 1.35, 95% CI 0.97–1.87; P = 0.08). The gene discussed is MAD2L1; the disease is cancer.